IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand (GerdQ)
This study has been completed.
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00999063
First received: October 20, 2009
Last updated: March 30, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a prospective , epidemiological, multi-centre, phase IV study, approximately 5,000 patients who suffer with upper gastrointestinal tract symptoms. Each patient will be assessed for GERD with GerdQ Thai Version.
| Condition |
|---|
| Upper GIT Symptoms |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Prevalence of GERD in Patients With upperGITsymptoms in Thailand |
Resource links provided by NLM:
Further study details as provided by AstraZeneca:
Primary Outcome Measures:
- Prevalence of gastroesophageal reflux disease (GERD) in patients presented with upper gastrointestinal tract symptoms
Secondary Outcome Measures:
- Response to various treatments for patients who have been diagnosed of GERD
| Enrollment: | 4108 |
| Study Start Date: | December 2009 |
| Study Completion Date: | February 2011 |
| Primary Completion Date: | February 2011 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Primary care clinic
Criteria
Inclusion Criteria:
- Provision of informed consent prior to any study specific procedures
- Female or male aged at least 18 years
- Patient must be having symptoms suggestive of upper gastrointestinal tract symptoms such as heart burn/ regurgitation
Exclusion Criteria:
- Involvement in the planning and /or conduct of the study (applies to both AstraZeneca staff and /or staff at study site
- Participation in a clinical study(excluding non-interventional study or registry) during the last 3 months
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00999063
Please refer to this study by its ClinicalTrials.gov identifier: NCT00999063
Locations
| Thailand | |
| Research Site | |
| Bangkok Noi, Bangkok, Thailand | |
| Research Site | |
| Muang, Bangkok, Thailand | |
| Research Site | |
| Pathumwan, Bangkok, Thailand | |
| Research Site | |
| Rajthevee, Bangkok, Thailand | |
| Research Site | |
| Ratchthewi, Bangkok, Thailand | |
| Research Site | |
| Maerim, Chiang Mai, Thailand | |
| Research Site | |
| Maung, Chiang Mai, Thailand | |
| Research Site | |
| Maung, Khon Kaen, Thailand | |
| Research Site | |
| Maung, Nakhon Sri Thammarat, Thailand | |
| Research Site | |
| Maung, Nakhonratchasima, Thailand | |
| Research Site | |
| Maung, Nakhonsawan, Thailand | |
| Research Site | |
| Maung, Nakornpathom, Thailand | |
| Research Site | |
| Muang, Nonthaburi, Thailand | |
| Research Site | |
| Klong Luang, Pathumthani, Thailand | |
| Research Site | |
| Maung, Phetchabun, Thailand | |
| Research Site | |
| Maung, Phuket, Thailand | |
| Research Site | |
| Maung, Rajburi, Thailand | |
| Research Site | |
| Maung, Roiet, Thailand | |
| Research Site | |
| Maung, Samut sakorn, Thailand | |
| Research Site | |
| Maung, Sukhothai, Thailand | |
| Research Site | |
| Maung, Trang, Thailand | |
| Research Site | |
| Maung, Ubonratchathani, Thailand | |
| Research Site | |
| Varin Chamrap, Ubonratchathani, Thailand | |
| Research Site | |
| Muang, Udon Thani, Thailand | |
| Research Site | |
| Maung, Uttaradit, Thailand | |
Sponsors and Collaborators
AstraZeneca
Investigators
| Principal Investigator: | Somchai Leelasukolvong, Dr. | Siriraj Hospital |
More Information
| Responsible Party: | Sompob Paibulsirijit, MD, Vice President Medical& Regulatory Affairs department, AstraZeneca |
| ClinicalTrials.gov Identifier: | NCT00999063 History of Changes |
| Other Study ID Numbers: |
NIS-GTH-NEX-2009/1 |
| Study First Received: | October 20, 2009 |
| Last Updated: | March 30, 2011 |
Keywords provided by AstraZeneca:
|
GerdQ |
Additional relevant MeSH terms:
|
Gastroesophageal Reflux Esophageal Motility Disorders Deglutition Disorders |
Esophageal Diseases Gastrointestinal Diseases Digestive System Diseases |
ClinicalTrials.gov processed this record on July 24, 2017